These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 13420740)

  • 1. [Initial epidemiological data on the possible preventive action of oral BCG in close contacts of leprosy patients].
    BECHELLI LM; QUAGLIATO R
    Rev Bras Leprol; 1956; 24(1-2):23-36. PubMed ID: 13420740
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of BCG vaccination among leprosy contacts: a cohort study.
    Düppre NC; Camacho LA; da Cunha SS; Struchiner CJ; Sales AM; Nery JA; Sarno EN
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):631-8. PubMed ID: 18514242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years.
    Sharma P; Mukherjee R; Talwar GP; Sarathchandra KG; Walia R; Parida SK; Pandey RM; Rani R; Kar H; Mukherjee A; Katoch K; Benara SK; Singh T; Singh P
    Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions.
    Moet FJ; Meima A; Oskam L; Richardus JH
    Lepr Rev; 2004 Dec; 75(4):310-26. PubMed ID: 15682969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lepromin reaction in lepers and contacts in the county of Uruguaiana (Rio Grande do Sul): 4 cases of positivization of the Mitsuda reaction by BCG].
    DE MENEZES D
    Rev Bras Leprol; 1953 Sep; 21(3):195-202. PubMed ID: 13167561
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
    Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
    Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Verification of the effect of BCG in leprosy patients during therapy; histopathological confirmation of lepromin reactions].
    RABELO NETO AV; AZULAY RD; OLIVEIRA SILVA EC; ANDRADE LM
    Rev Bras Leprol; 1956; 24(1-2):48-55. PubMed ID: 13420742
    [No Abstract]   [Full Text] [Related]  

  • 8. Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy.
    Moet FJ; Pahan D; Schuring RP; Oskam L; Richardus JH
    J Infect Dis; 2006 Feb; 193(3):346-53. PubMed ID: 16388481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reversal of Mitsuda reaction by oral BCG].
    ROSEMBERG J; CAMPOS NS; AUN JN
    Arq Min Leprol; 1953 Jul; 13(3):200-53. PubMed ID: 13159683
    [No Abstract]   [Full Text] [Related]  

  • 10. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positivization of Mitsuda reaction by oral and intradermal BCG (Rosenthal modified technic in children of lepers living at the Preventorium].
    SALOMAO A; FILHO EA; FERREIRA DL
    Arq Min Leprol; 1953 Oct; 13(4):297-307. PubMed ID: 13159686
    [No Abstract]   [Full Text] [Related]  

  • 12. [Positivation of Mitsuda reaction after BCG vaccination & its value in prevention of leprosy].
    FLOCH H
    Publ Inst Pasteur Guyane Fr Inini; 1957 Apr; 18(422):1-6. PubMed ID: 13522259
    [No Abstract]   [Full Text] [Related]  

  • 13. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
    Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population survey to determine risk factors for Mycobacterium leprae transmission and infection.
    Bakker MI; Hatta M; Kwenang A; Faber WR; van Beers SM; Klatser PR; Oskam L
    Int J Epidemiol; 2004 Dec; 33(6):1329-36. PubMed ID: 15256520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affection of immune zones in leprosy: a clinico-epidemiological study.
    Rajashekar TS; Singh G; Okade R; Harish MR
    Indian J Lepr; 2006; 78(3):269-77. PubMed ID: 17120510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
    Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral lesions in leprosy.
    Costa A; Nery J; Oliveira M; Cuzzi T; Silva M
    Indian J Dermatol Venereol Leprol; 2003; 69(6):381-5. PubMed ID: 17642946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tuberculoid reaction in leprosy following BCG administration].
    MONTESTRUC E; BERDONNEAU R; BENOIST J
    Arch Inst Pasteur Martinique; 1958; 11(3-4):108-10. PubMed ID: 13595998
    [No Abstract]   [Full Text] [Related]  

  • 19. [Observations furnished by applied experimentation; BCG in the prevention of leprosy].
    HADLER WA
    Rev Bras Leprol; 1957; 25(4):323-30. PubMed ID: 13568189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations furnished by applied experimentation; BCG in the prevention of leprosy].
    AZULAY RD
    Rev Bras Leprol; 1957; 25(4):331-41. PubMed ID: 13568190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.